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We  aimed  to determine  whether  background 18F-FDG  uptake  in  positron  emission  mammography  (PEM)
was  related  to  mammographic  density  or background  parenchymal  enhancement  in  breast  MRI.
Methods: We  studied  a total  of 52  patients  (mean  age,  50.9  years,  26 premenopausal,  26 postmenopausal)
with  newly  diagnosed  breast  cancer  who  underwent 18F-FDG  PEM  (positron  emission  mammography),
conventional  mammography  and  breast  MRI. The  background  mean 18F-FDG  uptake  value  on  PEM  was
obtained  by drawing  a user-deﬁned  region  of  interest  (ROI)  in a  normal  area  of  the  contralateral  breast.  We
reviewed  the  mammography  retrospectively  for  overall  breast  density  of  contralateral  breast  according  to
the  four-point  scale  (grade  1–4)  of the  Breast  Imaging  Reporting  and  Data  System  (BI-RADS)  classiﬁcation.
The  background  parenchymal  enhancement  of  breast  MRI was  classiﬁed  as  minimal,  mild,  moderate,  or
marked.  All  imaging  ﬁndings  were  interpreted  by  two  readers  in  consensus  without  knowledge  of  image
ﬁndings  of  other  modalities.
Results: Multiple  linear  regression  analysis  revealed  a  signiﬁcant  correlation  between  background 18F-
FDG  uptake  on PEM  and  mammographic  density  after  adjustment  for age  and  menopausal  status
(P  <  0.01),  but  not  between  background 18F-FDG  uptake  on  PEM  and  background  parenchymal  enhance-
ment  on  MRI.
Conclusion:  Background 18F-FDG  uptake  on  PEM  signiﬁcantly  increases  as  mammographic  density
increases.  Background  parenchymal  enhancement  in breast  MRI was  not  an  independent  predictor  of
18 uptak
he Athe  background F-FDG  
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1. Introduction
Positron emission mammography (PEM) is a high-resolution
molecular breast imaging technology that has shown high accuracy
in depicting breast cancer [1]. PEM uses 18F-FDG as the imaging
radiotracer, which identiﬁes the areas of increased glucose uti-
lization. The result of PEM imaging is a set of 12 slices in each of
the craniocaudal and mediolateral oblique positions, analogous to
mammography. Tomographic image set provides a detailed loca-
tion of the normal and abnormal 18F-FDG uptake as well as the
features or architectural patterns of any abnormal uptake. Theo-
retically, the degree of 18F-FDG uptake in the glandular tissues of
the normal breast can affect the detection of breast cancer [2].
Mammographically, the breast consists mainly of two compo-
Open access under CC BY-NC-ND license.nent tissues: ﬁbroglandular tissue and fat [3]. Breast density is a
measurement of the ratio between the radiodense epithelium and
stroma to the radiolucent fatty tissue. Mammographic density is a
strong independent risk factor for breast cancer [4,5]. Women  with
-ND license.
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ncreased mammographic density have been shown to have a four
o six fold increase in their risk of developing breast cancer [6]. It is
lso well accepted that high breast density decreases the sensitivity
f conventional mammography in detecting breast cancer [7].
Fibroglandular  parenchyma is enhanced at MR  images. The
erm background parenchymal enhancement refers to the nor-
al ﬁbroglandular tissue enhancement [8]. Prominent background
nhancement can obscure lesions and thus lower the sensitivity of
he study [9,10]. However, the degree of background enhancement
n breast MRI  and mammographic breast density do not necessarily
orrelate [10].
Some  studies have reported a relationship between the back-
round 18F-FDG uptake and mammographic density [2,11] or
ammographic density and background parenchymal enhance-
ent in breast MRI  [12]. To our knowledge, there is no study
ocusing on the relationship between the background 18F-FDG
ptake in PEM, mammographic density and background parenchy-
al enhancement in breast MRI. We  aimed to investigate the
nﬂuence of the mammographic density and background parenchy-
al enhancement in breast MRI  on the quantitative background
8F-FDG uptake in normal glandular breast tissue in PEM.
. Materials and methods
.1.  Patients
The institutional review board of our hospital approved this ret-
ospective study, and the requirement for informed consent was
aived. Among patients who were newly diagnosed with breast
ancer and scheduled for breast surgery at our center between
anuary and March 2010, a total of 52 patients (mean age, 51.1
ears; range, 30–73 years) who underwent a variety of breast exam-
nations including PEM, conventional mammography and breast
RI for preoperative evaluation were included in our study popu-
ation. 26 patients were premenopausal (mean age, 44 years; range
0–52 years) and 26 patients were postmenopausal (mean age 58
ears; range, 47–73 years).
.2.  PEM
After fasting for more than 8 h, the patients were intravenously
njected with 303 ± 46 MBq 18F-FDG. PEM images were acquired
4 ± 13 min  after injection using a dedicated scanner (PEM Flex Solo
I; Naviscan, San Diego, CA, USA). Craniocaudal (CC) and mediolat-
ral oblique (MLO) view images were acquired with the breasts
ompressed by PEM paddles. Images were acquired for 4 min  for
ach view. The overall imaging time for both breasts was <20 min.
EM images of each view were reconstructed by vendor-supplied
oftware and displayed as a series of 12 slices oriented parallel to
he compression paddles, with a slice thickness equal to 1/12 of the
ompressed breast thickness. PEM images were visually analyzed
y the consensus of two nuclear medicine physicians (J.S.E. with 7
ears of experience and K.W.K. with 10 years of experience in PET
nalysis). 18F-FDG uptake of the contralateral breast was measured
or quantitative analysis as values of uptake counts on PEM. For
he background breast, three circular ROIs approximately 1-cm in
iameter were drawn in contralateral breast tissue, and the mean
ptake counts of the three ROIs were averaged into a single value
13]. On PEM images, all ROIs were drawn more than 13 mm  away
rom the image margin to avoid artifacts at the edge [14].
.3.  MammographyMammography in two standard imaging planes (MLO and CC)
as performed using the Senographe 2000D (GE Healthcare, Mil-
aukee, WI,  USA) or the LORAD Selenia digital mammography uintadiology 82 (2013) 1738– 1742 1739
(Hologic, Boston, MA,  USA) for all patients. Two radiologists, one
with 6 years’ clinical experience (—) and one with 24 years’ clinical
experience (—), retrospectively reviewed in consensus the mam-
mography for the overall breast density according to the four-point
scale (grade 1–4) of the Breast Imaging Reporting and Data System
(BI-RADS) classiﬁcation [15].
2.4. Breast MRI
MRI  was performed with a 1.5 T commercially available MR
imager (Signa; GE Medical Systems, Milwaukee, WI,  USA) with
a dedicated phased-array breast coil and with subjects in the
prone position. Fat-suppressed, T2-weighted, fast spin-echo sag-
ittal images were also obtained. The following imaging parameters
were used: 5500/85.2; ﬂip angle: 90◦; image matrix: 256 × 160;
ﬁeld of view: 200 mm × 200 mm;  section thickness: 1.5 mm;  and
section gap: 0 mm.  A three-dimensional, T1-weighted, fast spoiled
gradient-echo sequence was  also performed with bilateral sagi-
ttal imaging, with one pre-contrast and four post-contrast dynamic
series obtained after 90, 270, 360, and 510 s. The imaging param-
eters were as follows: 6.5/2.5; ﬂip angle: 0◦; image matrix:
320 × 160; ﬁeld of view: 200 mm  × 200 mm;  section thickness:
1.5 mm;  and section gap: 0 mm.  Gadobutrol (gadolinium-DO3A-
butriol, Gadovist 1.0; Bayer Schering Pharma, Berlin, Germany) was
injected into an antecubital vein with an automated injector (Spec-
tris MR;  Medrad Europe, Maastricht, The Netherlands) at a dose of
0.1 mmol/kg of body weight and at a rate of 2 mL/s, and 20 mL  saline
was ﬂushed after the contrast agent injection. The MRI  examina-
tion was not always scheduled according to the patient’s menstrual
cycle. The MR  imaging was reviewed by two breast radiologists
in consensus, one with 6 years’ clinical experience (H.R.K.) and
one with 24 years’ clinical experience (W.K.M.) and background
parenchymal enhancement was classiﬁed as minimal, mild, mod-
erate, or marked, based on the pre-contrast, ﬁrst post-contrast
T1-weighted and subtraction images.
2.5. Statistical analysis
To  examine whether background 18F-FDG uptake on PEM was
associated with age, menopausal status, mammographic density,
and background parenchymal enhancement on MRI, linear regres-
sion analysis was performed. Statistical analyses were performed
using commercially available software (SPSS, v.19.0; Chicago, IL,
USA). Statistical signiﬁcance was assigned if the P-value was  <0.05.
3. Results
The patients’ characteristics are displayed in Table 1. Estimates
for mean, SD, minimum and maximum background 18F-FDG uptake
on PEM of 52 patients were 0.59, 0.26, 0.05 and 1.16, respectively.
Of the 52 mammograms, 5 (9.62%) were almost entirely fatty (grade
1), 12 (23.08%) had scattered ﬁbroglandular density (grade 2), 19
(36.54%) had heterogeneously dense (grade 3), 16 (30.77%) had an
extremely dense pattern (grade 4). Of the 52 MRI  examinations, 29
(55.8%) showed minimal background parenchymal enhancement,
13 (25.0%) showed mild enhancement, 5 (9.62%) showed moderate
enhancement, and 5 (9.62%) showed marked enhancement.
The mean ± SD background 18F-FDG uptake on PEM was
0.25 ± 0.13 in almost entirely fatty breasts (n = 5), 0.46 ± 0.21 in
breasts with scattered ﬁbroglandular density (n = 12), 0.62 ± 0.20
in heterogeneously dense breasts (n = 19), and 0.76 ± 0.23 in
extremely dense breasts (n = 16) (Fig. 1.). The mean ± SD back-
ground 18F-FDG uptake on PEM was 0.50 ± 0.24 in breasts with
minimal background parenchymal enhancement in breast MRI
(n = 29), 0.64 ± 0.26 in breasts with mild enhancement (n = 13),
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Table 1
Menopausal status, mammographic density, and MR background parenchymal
enhancement  in the 52 patients.
Variables N = 52
Age (yr) <40 7 (13.46%)
41–50  16 (30.77%)
>51  29 (55.77%)
Menopausal status Premenopause 26 (50%)
Menopause  26 (50%)
Mammographic
density
Grade 1 5 (9.62%)
Grade  2 12 (23.08%)
Grade  3 19 (36.54%)
Grade  4 16 (30.77%)
BPE* on breast MRI Minimal 29 (55.77%)
Mild  13 (25.0%)
Moderate  5 (9.62%)
Severe  5 (9.62%)
Evaluated Right 28 (53.85%)
0
0
(
u
n
n
F
d
T
Rcontralateral breast Left  24 (46.15%)
* BPE, background parenchymal enhancement.
.70 ± 0.22 in breasts with moderate enhancement (n = 5), and
.86 ± 0.15 in breasts with marked enhancement (n = 5) (Fig. 2).
The background 18F-FDG uptake negatively correlated with age
Spearman’s  −0.48, P < 0.01). The average background 18F-FDG
ptake of the premenopausal patients (0.74 ± 0.24, n = 26) was sig-
iﬁcantly higher than that of postmenopausal patients (0.43 ± 0.16,
 = 26, P < 0.01).
ig. 1. Mean background FDG uptake on PEM as a function of mammographic breast
ensity.
able 2
esults of multiple regression analysis for independent factors for predicting the backgro
Variable Parameter estimate 
Age 0.01 
Menopausal  status 0.39 
Mammographic
density
Ref:  grade 1
Grade  2 0.24 
Grade  3 0.36 
Grade  4 0.34 
BPE  on MRI Ref: minimal
Mild 0.10 
Moderate 0.17 
Severe  0.19 Fig. 2. Mean background FDG uptake on PEM as a function of background parenchy-
mal  enhancement in breast MRI.
Multiple linear regression analysis revealed mammographic
density as an independent predictor of the background 18F-FDG
uptake on PEM after adjustment for age and menopausal sta-
tus (P < 0.01). However, background parenchymal enhancement in
breast MRI  was  not an independent predictor of the background
18F-FDG uptake on PEM (Table 2).
When  analyzing the background parenchymal enhancement on
MRI  by mammographic density grades, we found that the patients
with dense breasts (heterogeneously dense or extremely dense)
exhibited a signiﬁcantly higher proportion of moderate or marked
background enhancement, at 28.6% (10/35), compared with those
who had fatty breasts (almost entirely fatty or scattered ﬁbroglan-
dular density), at 0% (0/17) (Table 3, McNemar’s test, P < 0.01).
4. Discussion
In the current study, an increase in mammographic density cor-
related with quantitatively increased background 18F-FDG uptake
on PEM. Previously, Vranjesevic et al., [2] showed that dense
breasts exhibit a signiﬁcantly higher 18F-FDG uptake than do fatty
breasts. The biologic mechanisms explaining the association of
overall higher background FDG uptake in dense breast tissue are not
clear. One possible explanation is that dense breasts contain more
cells per volume than fatty breasts [16]. As mammographic breast
density inﬂuences the mammographic sensitivity, the degree of
background 18F-FDG uptake may  inﬂuence the sensitivity of PEM.
Berg et al. reported that MRI  sensitivity at 14 of 15 (93%) was
higher than PEM at three of 15 (20%) in the evaluation of the con-
tralateral breast and patchy, heterogeneous background uptake of
und 18F-FDG uptake on PEM.
Standard error 95% Conﬁdence Interval P-value
0.00 0.00 0.02 0.03
0.09 0.20 0.58 <0.01
0.10 0.05 0.44 0.02
0.10 0.16 0.55 <0.01
0.11 0.11 0.56 <0.01
0.07 −0.03 0.23 0.13
0.10 −0.03 0.37 0.08
0.10 −0.01 0.40 0.06
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Table 3
Background parenchymal enhancement in MRI  compared for the mammographic
breast  density.
Mammographic density
Grade 1 Grade 2 Grade 3 Grade 4
BPE in MRI
Minimal 5 9 10 5 29
Mild 0 3 5 5 13
Moderate 0 0 4 1 5
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8F-FDG had interfered with interpretation of two contralateral
reast cancers on PEM [17]. These ﬁndings suggest that there may
e weakly 18F-FDG avid tumors that are obscured by dense tissue
f increased background activity in PEM. A description of the back-
round 18F-FDG uptake should be included in the PEM report to
nform physicians about the sensitivity of the examination.
Present study demonstrated that background parenchymal
nhancement in breast MRI  was not an independent predictor of
he background 18F-FDG uptake on PEM unlike mammographic
ensity. Women  showing minimal or mild background parenchy-
al enhancement were likely to have a variable background
8F-FDG uptake. A few studies have reported a potential correlation
etween the mammographic density and background parenchy-
al enhancement in breast MRI. Cubuk et al. found no correlation
etween the mammographic density and background parenchymal
nhancement in breast MRI  in either premenopausal or post-
enopausal women [18]. Klifa et al. also found no signiﬁcant
orrelation between the MR  density and enhancement levels in
heir normal population [19]. In our study, however, there were sig-
iﬁcant differences in the distribution of mammographic density
nd background parenchymal enhancement in breast MRI. Patients
ith heterogeneously or extremely dense breasts exhibited a sig-
iﬁcantly higher proportion of moderate or marked background
arenchymal enhancement on MRI  compared with those classiﬁed
s having almost entirely fatty or scattered ﬁbroglandular den-
ity. Because there can be signiﬁcant variations in the degree of
ackground parenchymal enhancement throughout the menstrual
ycle [20], our result may  be explained by our MRI  examinations
ot being scheduled according to the patients’ menstrual cycle and
uggests that the breast MRI  should be performed with adjust-
ent for the phase in the patients’ menstrual cycle to minimize the
imitations imposed by moderate or marked background enhance-
ent, if possible. In the current study, all cases with almost entirely
atty breast density (n = 5) showed minimal background enhance-
ent on breast MRI, and that is consistent with the previous results
eported by Uematsu et al. [21]. Thus, imaging breast MR  of women
ith an almost entirely fatty breast may  be scheduled regardless
f menstrual cycle.
Main  limitation of the present study is its retrospective design,
hich unavoidably introduces selection bias and limits the gen-
ral application of the results. The small sample size is also a
imitation, which is not sufﬁcient for correct statistical analysis.
ven though confounding factors may  have been reduced by the
ultivariate analysis of the main variables related to background
8F-FDG uptake on PEM, some selection bias still remained, because
e used contralateral breasts of patients with known breast can-
er. In addition, we did not evaluate the reproducibility of the
ammographic density and background enhancement interpre-
ation. The qualitative interpretation of mammographic density
nd background parenchymal enhancement on MRI  is subjective.
his indicates the need for a more objective and clinically feasible
echnique to quantify the mammographic density and background
arenchymal enhancement in MRI.
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5.  Conclusion
To our knowledge, this is the ﬁrst study to examine the
impact of the mammographic density and background parenchy-
mal enhancement in breast MRI  on the background breast tissue
18F-FDG uptake in PEM. In the current study, the background
18F-FDG uptake on PEM signiﬁcantly increases as mammographic
density increases. Although our results do not directly address
the effect of background 18F-FDG uptake on accuracy of PEM,
these initial results suggest that increased background FDG uptake
might have an important effect on the diagnostic accuracy of PEM.
As mammographic density decreases the detection rate of breast
cancer at mammography, the sensitivity can be affected by the
background 18F-FDG uptake on PEM. Further research is needed to
clarify the effect of breast background tissue characteristics across
imaging modalities on cancer detection.
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